Theralip SA provides an automated device and sterile disposable kits to process autologous adipose tissue into injectable or cryopreservable tissue containing adipose-derived stem cells. The system includes an electronic service unit and preassembled sterile kits and is intended for direct infusion or cryopreservation; applications include orthopedics, general surgery, plastic surgery and gynecology.
AI-generated
Offering
Products & services
Industry:Research & Development
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Device for processing autologous adipose tissue for injectable or cryopreservable products; with Service Unit, sterile disposable kits and automated process steps.
Application of autologous adipose tissue
Use of one’s own adipose tissue in orthopaedics, general surgery, gynaecology and plastic surgery; for chondropathies, tendinopathies, fistulas, ulcers, vaginal atrophy and aesthetic procedures.
Cryopreservable cell therapy product
Cryopreservable product based on autologous adipose tissue globules with adipose-derived stem cells; intended for storage in biobanks and later use.
Sterile disposable kits
Pre-assembled sterile kits with everything required for the procedure; specific kits for different application areas and for modulating adipose tissue size.
Knowledge
No knowledge articles yet
Once Theralip SA has claimed this profile, we'll publish editorial articles and case studies here together.